Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
10:30am, Tuesday, 15'th Oct 2024
STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Pet DNA Testing Market Size, Share and Trends Analysis 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global pet DNA testing
KBRA Assigns Preliminary Ratings to Freddie Mac's STACR 2024-DNA3
11:01am, Thursday, 03'rd Oct 2024
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to 24 classes from Freddie Mac Structured Agency Credit Risk (STACR®) REMIC 2024-DNA3 Notes, Freddie Mac STACR REMIC
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing
07:03am, Thursday, 03'rd Oct 2024
BOSTON & OTTAWA, Ontario--(BUSINESS WIRE)-- #AAV--Virica and Ginkgo announce a strategic partnership to enhance the productivity of adeno-associated virus (AAV) gene therapy manufacturing platforms.
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade
07:21pm, Thursday, 26'th Sep 2024
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $7.70, moving -0.77% from the previous trading session.
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
04:05pm, Wednesday, 25'th Sep 2024
Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
04:05pm, Wednesday, 25'th Sep 2024
PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA stabilization from urine // QIAGEN to commercial
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
07:01am, Tuesday, 24'th Sep 2024
BOSTON and CHESTERFIELD, Mo. , Sept. 24, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced its new partne
OAKLAND, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the Northern District of California Oakland Division has approved the following an
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
09:00am, Wednesday, 18'th Sep 2024
STONY BROOK, NY / ACCESSWIRE / September 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it recei
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
07:01am, Wednesday, 18'th Sep 2024
BOSTON , Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoi
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
06:07pm, Tuesday, 17'th Sep 2024
The biotech rolled out two new healthtech innovations. One is a large language model (LLM) developed with its partner Alphabet.
- Co-Hosts Seminar with mRNA CDMO Kudo Bio to Demonstrate Linea IVT Capability for Rapid mRNA Manufacturing - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APD
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
09:00am, Tuesday, 17'th Sep 2024
- Recurring and Accelerated Receipt of Order Reflects Customer Commitment to Linea DNA - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
08:01am, Tuesday, 17'th Sep 2024
Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API
